Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,106 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Randomized comparison of the efficacy and safety of zotarolimus-eluting stents vs. sirolimus-eluting stents for percutaneous coronary intervention in chronic total occlusion--CAtholic Total Occlusion Study (CATOS) trial.
Park HJ, Kim HY, Lee JM, Choi YS, Park CS, Kim DB, Her SH, Koh YS, Park MW, Kwon BJ, Kim PJ, Chang K, Chung WS, Seung KB. Park HJ, et al. Among authors: choi ys. Circ J. 2012;76(4):868-75. doi: 10.1253/circj.cj-11-1021. Epub 2012 Jan 25. Circ J. 2012. PMID: 22277317 Free article. Clinical Trial.
The effect of cilostazol on stent thrombosis after drug-eluting stent implantation.
Jeon DS, Yoo KD, Park CS, Shin DI, Her SH, Park HJ, Choi YS, Kim DB, Lee CM, Park CS, Kim PJ, Moon KW, Jang KY, Kim HY, Chung WS, Seung KB, Kim JH, Choi KB. Jeon DS, et al. Among authors: choi kb, choi ys. Korean Circ J. 2010 Jan;40(1):10-5. doi: 10.4070/kcj.2010.40.1.10. Epub 2010 Jan 27. Korean Circ J. 2010. PMID: 20111647 Free PMC article.
Soluble receptor for advanced glycation end products is associated with in-stent restenosis in patients with type 2 diabetes with drug-eluting coronary stents.
Park HJ, Seo SM, Shin WS, Kim HY, Choi YS, Koh YS, Youn SG, Park MW, Chang K, Kim PJ, Jung HO, Baek SH, Chung WS, Seung KB, Yoo KD. Park HJ, et al. Among authors: choi ys. Coron Artery Dis. 2011 Jan;22(1):12-7. doi: 10.1097/mca.0b013e328340b210. Coron Artery Dis. 2011. PMID: 21197704 Clinical Trial.
High-density lipoprotein cholesterol as a predictor of clinical outcomes in patients achieving low-density lipoprotein cholesterol targets with statins after percutaneous coronary intervention.
Seo SM, Choo EH, Koh YS, Park MW, Shin DI, Choi YS, Park HJ, Kim DB, Her SH, Lee JM, Park CS, Kim PJ, Moon KW, Chang K, Kim HY, Yoo KD, Jeon DS, Chung WS, Park YG, Seung KB; Catholic University of Korea, Percutaneous Coronary Intervention Registry investigators. Seo SM, et al. Among authors: choi ys. Heart. 2011 Dec;97(23):1943-50. doi: 10.1136/hrt.2011.225466. Epub 2011 Jun 10. Heart. 2011. PMID: 21665885 Free PMC article.
Rates of coronary intervention due to de novo significant atherosclerosis and cardiac death are very low in Korean patients with vasospastic angina: 36-month follow-up results of the Vasospastic Angina in the Catholic Medical Center (VA-CMC) registry.
Shin DI, Baek SH, Seo SM, Koh YS, Choi YS, Kim DB, Her SH, Kim PJ, Lee JM, Kim HY, Yoo KD, Seung KB. Shin DI, et al. Among authors: choi ys. Circ J. 2012;76(11):2681-9. doi: 10.1253/circj.cj-12-0586. Epub 2012 Aug 8. Circ J. 2012. PMID: 22878408 Free article. Clinical Trial.
Clinical benefit of long-term use of dual antiplatelet therapy for acute myocardial infarction patients with the PEGASUS-TIMI 54 criteria.
Lee KY, Hwang BH, Choo EH, Lim S, Kim CJ, Kim JJ, Byeon J, Choi IJ, Oh GC, Choi YS, Yoo KD, Chung WS, Ahn Y, Jeong MH, Chang K. Lee KY, et al. Among authors: choi ys, choi ij. Front Cardiovasc Med. 2022 Nov 17;9:1017533. doi: 10.3389/fcvm.2022.1017533. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36465433 Free PMC article.
Immunologic and non-immunologic complications of a third kidney transplantation.
Kim HS, Kim JY, Kang EJ, Choi YS, Kim JI, Moon IS, Choi BS, Park CW, Yang CW, Kim YS, Chung BH. Kim HS, et al. Among authors: choi ys, choi bs. Korean J Intern Med. 2015 Sep;30(5):657-64. doi: 10.3904/kjim.2015.30.5.657. Epub 2015 Aug 27. Korean J Intern Med. 2015. PMID: 26354060 Free PMC article.
Efficacy and toxicity of the combination chemotherapy of thalidomide, alkylating agent, and steroid for relapsed/refractory myeloma patients: a report from the Korean Multiple Myeloma Working Party (KMMWP) retrospective study.
Kwon J, Min CK, Kim K, Han JJ, Moon JH, Kang HJ, Eom HS, Kim MK, Kim HJ, Yoon DH, Lee JO, Lee WS, Lee JH, Lee JJ, Choi YS, Kim SH, Yoon SS. Kwon J, et al. Among authors: choi ys. Cancer Med. 2017 Jan;6(1):100-108. doi: 10.1002/cam4.970. Epub 2016 Dec 1. Cancer Med. 2017. PMID: 27905203 Free PMC article.
3,106 results